Bladder Cancer - Results from #10

REVIEW UroToday

Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer. October 29, 2024

Long-term oncologic outcomes and complications of robot-assisted radical cystectomy for the treatment of urothelial carcinoma of the bladder. October 29, 2024

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION). October 28, 2024

Trends in the use of immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumors. October 28, 2024

Artificial intelligence-based assessment of pre-operative body composition is associated with early complications after radical cystectomy. October 25, 2024

Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274. October 25, 2024

Comparing direct medical care costs of patients with bladder cancer who received an ileal conduit vs. neobladder in the year following cystectomy. October 24, 2024

VI-RADS-Based Algorithm for Bladder Cancer Management Randomized Retrospective Study. October 24, 2024

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs. October 23, 2024

Comparative effectiveness of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer. October 23, 2024

Neoadjuvant chemotherapy before radical cystectomy in patients with organ-confined and non-organ-confined urothelial carcinoma. October 22, 2024

En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-analysis of Oncological, Histopathological, and Surgical Outcomes. October 22, 2024

The evolving role of multidisciplinary teams in optimizing Non-Muscle Invasive bladder cancer Care. October 21, 2024

Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39. October 21, 2024

National audit of patient reported experience of radical cystectomy for bladder cancer pathways. October 18, 2024

Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes. October 18, 2024

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial October 17, 2024

Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec. October 17, 2024

Effects of Intraoperative Opioid Use and a Combined Anesthesia Protocol in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder-A Single-Center Experience. October 17, 2024

The Role of Maximal TURBT in Muscle-Invasive Bladder Cancer: Balancing Benefits in Bladder Preservation and Beyond. October 17, 2024

Page 1 of 517